XCOPRI 150 MG TABLET

cenobamate
$39.9393per EA
DEA Schedule CV

Strength

150 mg/1

NDC

71699015030

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

1/1/2026

Active Ingredients

CENOBAMATE

Approval Type

New Drug (NDA)

FDA Application

NDA212839

On Market Since

3/12/2020

Pharmacological Classes

Cytochrome P450 2B6 Inducers
Cytochrome P450 2B6 Inhibitors
Cytochrome P450 2C19 Inhibitors
Cytochrome P450 2C8 Inducers
Cytochrome P450 3A Inhibitors
Cytochrome P450 3A4 Inducers
GABA A Receptor Positive Modulators
Sodium Channel Antagonists

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+3.1%

1Y

+2.7%

3Y

+12.1%

5Y

N/A

All

+17.7%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.